Patents by Inventor Rajagopalan Raghavan

Rajagopalan Raghavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240097749
    Abstract: Methods, systems, and devices for wireless communication are described. In some systems, a user equipment (UE) may transmit, to a network entity, a first signal including a request to update a resolution of a phase shifting operation associated with beam-based communications. The UE may receive, from the network entity, a second signal approving the request. The UE may communicate using a beam according to an updated resolution of the phase shifting operation based on the second signal approving the request. Additionally, or alternatively, the UE may transmit a first signal including a request to suspend a beam refinement process based on the resolution of the phase shifting operation. The UE may receive a second signal approving the request to suspend the beam refinement process. The UE may communicate with the network entity using a beam based on suspending further beam refinement in response to the second signal.
    Type: Application
    Filed: September 16, 2022
    Publication date: March 21, 2024
    Inventors: Vasanthan Raghavan, Shrenik Patel, Rajagopalan Rangarajan, Damin Cao, Kang Yang, Jung Ho Ryu, Junyi Li
  • Publication number: 20070221217
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: June 1, 2007
    Publication date: September 27, 2007
    Inventors: MARY FLAMENT-GARCIA, Keith Cromack, David Loffredo, Rajagopalan Raghavan, George Ramsay, Earl Speicher
  • Publication number: 20060148906
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: February 27, 2006
    Publication date: July 6, 2006
    Inventors: Christopher Bieniarz, Steve Chang, Keith Cromack, Shuyen Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl Speicher, Honorata Stelmach
  • Publication number: 20040048932
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: June 26, 2003
    Publication date: March 11, 2004
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Patent number: 6677492
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: January 13, 2004
    Assignee: Abbott Laboratories
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorats A. Stelmach
  • Publication number: 20030200963
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 30, 2003
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Publication number: 20030130359
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: July 3, 2002
    Publication date: July 10, 2003
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffrado, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Patent number: 6558679
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: May 6, 2003
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Patent number: 6444859
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: September 3, 2002
    Assignees: Abbott Laboratories, Central Glass Company LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Publication number: 20020016373
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: August 8, 2001
    Publication date: February 7, 2002
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Patent number: 6288127
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: September 11, 2001
    Assignee: Abbott Laboratories & Central Glass Co LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Publication number: 20010000729
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 3, 2001
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Patent number: 6162443
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: December 19, 2000
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Patent number: 6083514
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polymethylpentene. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: July 4, 2000
    Assignee: Abbott Laboratories
    Inventors: Steve H. Chang, Keith R. Cromack, Mary Jane Flament-Garcia, Joan Garapolo, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Patrick Rice, Jeffrey Setesak
  • Patent number: 6074668
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polyethylene napthalate. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: June 13, 2000
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Steve H. Chang, Keith R. Cromack, Joan Garapolo, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Patrick Rice, Jeffrey Setesak
  • Patent number: 5990176
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: November 23, 1999
    Assignees: Abbott Laboratories, Central Glass Company Ltd.
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Patent number: 5922754
    Abstract: The present invention provides novel paclitaxel formulations which may be terminally sterilized and show long term stability in water containing admixtures.
    Type: Grant
    Filed: October 2, 1998
    Date of Patent: July 13, 1999
    Assignee: Abbott Laboratories
    Inventors: Mark K. Burchett, Cynthia A. Coddington, Rajagopalan Raghavan, Earl R. Speicher